Biruloquinone, an acetylcholinesterase inhibitor produced by lichen-forming fungus Cladonia macilenta

Journal of Microbiology and Biotechnology

Volumn 23, Issue 2, 2013, Pages 161-166

  Luo, Heng ^a   Li, Changtian ^b   Kim, Jin Cheol ^c   Liu, Yan Peng ^a   Jung, Jae Sung ^d   Koh, Young Jin ^d   Hur, Jae Seoun ^d  

^a JIANGSU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c Korea Research Institute of Chemical Technology   (South Korea)

^d Sunchon National University   (South Korea)

Author keywords

Acetylcholinesterase inhibitor; Biruloquinone; Cladonia macilenta; Lichen forming fungus

Indexed keywords

BIRULOQUINONE; CHOLINESTERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHOLINESTERASE INHIBITION; CLADONIA; CLADONIA MACILENTA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; MASS SPECTROMETRY; NEUROPROTECTION; PC12 CELL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84873808638     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1207.07016     Document Type: Article

References (21)

1. Armone, A., G. Nasini, and O. V. de Para. 1991. A reinvestigation of the structure of biruloquinone, a 9,10-phenanthrenequinone isolated from Mycosphaerella rubella. Phytochemistry 31: 2729-2731.
2. Barkats, M., S. Millecamps, P. Abrioux, M. C. Geoffroy, and J. Mallet. 2000. Overexpression of glutathione peroxidase increases the resistance of neuronal cells to Aβ-mediated neurotoxicity. J. Neurochem. 75: 1438-1446.
3. Boldogh, I., M. L. Kruzel, and T. M. Colostrinin. 2008. An oxidative stress modulator for prevention and treatment of agerelated disorders. J. Alzheimers Dis. 13: 303-321.
4. Ellman, G. L. and K. D. Courtney. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88-90.
5. Keston, A. S. and R. Brandt. 1965. The fluorometric analysis of ultramicro quantities of hydrogen peroxide. Anal. Biochem. 11: 1-5.
6. Krivoshchekova, O. E., L. S. Stepanenko, N. P. Mishchenko, V. A. Denisenko, and O. B. Maksimov. 1983. A study of aromatic metabolites of lichens of the family Parmeliaceae. II. Pigments. Chem. Nat. Comp. 19: 270-274.
7. Lenta, B. N., K. P. Devkota, S. Ngouela, F. F. Boyom, Q. Naz, M. I. Choudhary, E. Tsamo, P. J. Rosenthal, and N. Sewald. 2008. Anti-plasmodial and cholinesterase inhibiting activities of some constituents of Psorospermum glaberrimum. Chem. Pharm. Bull. 56: 222-226.
8. Lovell, M. A. and W. R. Markesbery. 2007. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J. Neurosci. Res. 85: 3036-3040.
9. Moon, J. H., S. Y. Kim, H. G. Lee, S. U. Kim, and Y. B. Lee. 2008. Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar β amyloid peptide (1-42)-stimulated microglia. Exp. Mol. Med. 40: 11-18.
10. Mukherjee, P. K., V. Kumar, M. Mal, and P. J. Houghton. 2007. Acetylcholinesterase inhibitors from plants. Phytomedicine 14: 289-300.
11. Ogura, H., T. Kosasa, Y. Kuriya, and Y. Yamanishi. 2000. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find. Exp. Clin. Pharmacol. 22: 609-613.
12. Oksanen, I. 2006. Ecological and biotechnological aspects of lichens. Appl. Microbiol. Biotechnol. 73: 723-734.
13. Roberson, E. and L. Mucke. 2006. 100 years and counting: Prospects for defeating Alzheimer's disease. Science 314: 781-784.
14. Sayre, L. M., G. Perry, and M. A. Smith. 2008. Oxidative stress and neurotoxicity. Chem. Res. Toxicol. 21: 172-188.
15. Shi, D. H., J. H. Wu, H. M. Ge, and R. X. Tan. 2009. Protective effect of hopeahainol A, a novel acetylcholinesterase inhibitor, on hydrogen peroxide-induced injury in PC12 cells. Environ. Toxicol. Pharmacol. 28: 30-36.
16. Small, D. H. 2005. Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: Do we need new inhibitors? Expert Opin. Emerg. Drugs 10: 817-825.
17. Stocker-Wörgötter, E. 2008. Metabolic diversity of lichenforming ascomycetous fungi: Culturing, polyketide and shikimate metabolite production, and PKS genes. Nat. Prod. Rep. 25: 188-200.
18. Sultana, R., S. Newman, H. Mohmmad-Abdul, J. N. Keller, and D. A. Butterfield. 2004. Protective effect of the xanthate, D609, on Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress in primary neuronal cells. Free Radic. Res. 38: 449-458.
19. Terry, A. V. and J. J. Buccafusco. 2003. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 306: 821-827.
20. Wimo, A., B. Winblad, and L. Jönsson. 2007. An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement. 3: 81-91.
21. Yamamoto, Y. 2002. Discharge and germination of lichen ascospores in the laboratory. Lichenology 1: 11-22.(in Japanese)